研究人员从过滤的人的血液中数百种蛋白质找到一种被称为病毒抑制肽(VIRIP)的肽分子。
In this study the researchers found a fraction of a peptide molecule called Virus-Inhibitory peptide (VIRIP) by screening hundreds of proteins from filtered human blood.
这种被称为VIRIP（病毒抑制肽）的分子，结合到HIV病毒表面一种叫做gp41的道钉样蛋白质上。
The molecule, known as VIRIP (virus-inhibitory peptide), binds to a spiky protein on the surface of the HIV virus called gp41.
结果显示此种肽能够抑制病毒附着细胞受体最终阻止感染。
Results showed the peptide capable of inhibiting viral attachment to the cellular receptor ultimately preventing infection.
某些抗菌肽还具有抗病毒、抗真菌及抑制癌细胞生长的作用。
Some of them are active against some viruses, fungi and cancer cell lines, and harmless to human normal cells.
扶素生物自主开发的第一个产品：艾滋病病毒膜融合抑制剂——西夫韦肽。
The lead drug candidate in FusoGen's pipeline is Sifuvirtide, an HIV fusion inhibitor. One of the first fusion inhibitor drug against HIV.
扶素生物自主开发的第一个产品：艾滋病病毒膜融合抑制剂——西夫韦肽。
The lead drug candidate in FusoGen's pipeline is Sifuvirtide, an HIV fusion inhibitor. One of the first fusion inhibitor drug against HIV.
应用推荐